Search Results - "Swaisland, H.C." :: K.UTB vyhledávací portál

Do gastrointestinal transit parameters influence the pharmacokinetics of gefitinib?

by Wilson, C.G., O’Mahony, B., Connolly, S.M., Cantarini, M.V., Farmer, M.R., Dickinson, P.A., Smith, R.P., Swaisland, H.C.
Published in International journal of pharmaceutics (06.07.2009)

Get full text

Journal Article

Loading…

A sensitive assay for ZD1839 (Iressa ) in human plasma by liquid–liquid extraction and high performance liquid chromatography with mass spectrometric detection: validation and use in Phase I clinical trials

by Jones, H.K, Stafford, L.E, Swaisland, H.C, Payne, R
Published in Journal of pharmaceutical and biomedical analysis (20.06.2002)

Get full text

Journal Article

Loading…

Pharmacokinetics of single and multiple oral doses of zd 1839 (‘Iressa’), a specific epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki), in healthy male volunteers

by Swaisland, H.C., Smith, R., Jones, H., Farebrother, J., Laight, A.
Published in European journal of cancer (1990) (01.04.2001)

Get full text

Journal Article

Do gastrointestinal transit parameters influence the pharmacokinetics of gefitinib?

A sensitive assay for ZD1839 (Iressa ) in human plasma by liquid–liquid extraction and high performance liquid chromatography with mass spectrometric detection: validation and use in Phase I clinical trials

Pharmacokinetics of single and multiple oral doses of zd 1839 (‘Iressa’), a specific epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki), in healthy male volunteers

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database